Personal profile
Fingerprint
Dive into the research topics where Michael Johnston is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 4 Article
-
Antitumor activity of death receptor 5-targeted camptothecin-loaded nanoparticles in murine syngeneic models
Boland, A. J., Greene, M. K., Herron, Ú. M., Johnston, M. C., Smyth, P., Yagita, H., Longley, D. B. & Scott, C. J., 10 Dec 2025, (Early online date) In: Biomacromolecules. 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Downloads (Pure) -
Lysosomal cysteine proteases are mediators of cell death in macrophages following exposure to amorphous silica nanoparticles
Ishaq, F., Sereesongsaeng, N., Johnston, M. C., Scott, C. J. & Burden, R. E., 01 Apr 2022, In: Chemico-Biological Interactions. 356, 8 p., 109882.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Link opens in a new tab Citations (Scopus)69 Downloads (Pure) -
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models
Johnston, M., Nicoll, J., Redmond, K., Smyth, P., Greene, M., McDaid, W., Crawford, N., Stott, K., Fox, J., Longley, D. & Scott, C., 10 Aug 2020, In: Journal of Controlled Release. 324, p. 610-619 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile24 Link opens in a new tab Citations (Scopus)347 Downloads (Pure) -
Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy
Johnston, M. C. & Scott, C. J., Dec 2018, In: Drug Discovery Today: Technologies. 30, p. 63-69 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile83 Link opens in a new tab Citations (Scopus)1317 Downloads (Pure)